Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-02-24 @ 7:04 AM
Study NCT ID:
NCT02899793
Status:
COMPLETED
Last Update Posted:
2025-06-11
First Post:
2016-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Sponsor:
Yale University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1605017712
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |